211 related articles for article (PubMed ID: 8924606)
1. Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole.
Skiles GL; Yost GS
Chem Res Toxicol; 1996; 9(1):291-7. PubMed ID: 8924606
[TBL] [Abstract][Full Text] [Related]
2. Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes.
Lanza DL; Yost GS
Drug Metab Dispos; 2001 Jul; 29(7):950-3. PubMed ID: 11408359
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
[TBL] [Abstract][Full Text] [Related]
4. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
Ebner T; Meese CO; Eichelbaum M
Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene.
Wang H; Lanza DL; Yost GS
Arch Biochem Biophys; 1998 Jan; 349(2):329-40. PubMed ID: 9448722
[TBL] [Abstract][Full Text] [Related]
7. Single mutations change CYP2F3 from a dehydrogenase of 3-methylindole to an oxygenase.
Kartha JS; Skordos KW; Sun H; Hall C; Easterwood LM; Reilly CA; Johnson EF; Yost GS
Biochemistry; 2008 Sep; 47(37):9756-70. PubMed ID: 18717595
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 3-methylindole bioactivation by the cytochrome P-450 suicide substrates 1-aminobenzotriazole and alpha-methylbenzylaminobenzotriazole.
Huijzer JC; Adams JD; Jaw JY; Yost GS
Drug Metab Dispos; 1989; 17(1):37-42. PubMed ID: 2566467
[TBL] [Abstract][Full Text] [Related]
9. Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2.
Guengerich FP; Krauser JA; Johnson WW
Biochemistry; 2004 Aug; 43(33):10775-88. PubMed ID: 15311939
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of specific antibodies: utilization to predict organ- and species-selective pneumotoxicity of 3-methylindole.
Kaster JK; Yost GS
Toxicol Appl Pharmacol; 1997 Apr; 143(2):324-37. PubMed ID: 9144449
[TBL] [Abstract][Full Text] [Related]
11. Evidence supporting the formation of 2,3-epoxy-3-methylindoline: a reactive intermediate of the pneumotoxin 3-methylindole.
Skordos KW; Skiles GL; Laycock JD; Lanza DL; Yost GS
Chem Res Toxicol; 1998 Jul; 11(7):741-9. PubMed ID: 9671536
[TBL] [Abstract][Full Text] [Related]
12. Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells.
Lanza DL; Code E; Crespi CL; Gonzalez FJ; Yost GS
Drug Metab Dispos; 1999 Jul; 27(7):798-803. PubMed ID: 10383923
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and bioactivation of 3-methylindole by Clara cells, alveolar macrophages, and subcellular fractions from rabbit lungs.
Thornton-Manning JR; Nichols WK; Manning BW; Skiles GL; Yost GS
Toxicol Appl Pharmacol; 1993 Oct; 122(2):182-90. PubMed ID: 8212000
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding.
Thornton-Manning J; Appleton ML; Gonzalez FJ; Yost GS
J Pharmacol Exp Ther; 1996 Jan; 276(1):21-9. PubMed ID: 8558432
[TBL] [Abstract][Full Text] [Related]
15. Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
Nocerini MR; Yost GS; Carlson JR; Liberato DJ; Breeze RG
Drug Metab Dispos; 1985; 13(6):690-4. PubMed ID: 2867872
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 3-methylindole in human tissues.
Ruangyuttikarn W; Appleton ML; Yost GS
Drug Metab Dispos; 1991; 19(5):977-84. PubMed ID: 1686246
[TBL] [Abstract][Full Text] [Related]
17. The effect of 3-methylindole on superoxide and hydrogen peroxide production and NADPH oxidation by goat lung microsomes.
Laegreid WW; Breeze RG
Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):387-97. PubMed ID: 2986255
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of a novel 3-substituted indole-containing TNF-alpha inhibitor: dehydrogenation and inactivation of CYP3A4.
Sun H; Yost GS
Chem Res Toxicol; 2008 Feb; 21(2):374-85. PubMed ID: 18095656
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pulmonary CYP4B2, specific catalyst of methyl oxidation of 3-methylindole.
Carr BA; Ramakanth S; Dannan GA; Yost GS
Mol Pharmacol; 2003 May; 63(5):1137-47. PubMed ID: 12695542
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of lung-selective cytochrome P450 CYP2F enzymes.
Kartha JS; Yost GS
Drug Metab Dispos; 2008 Jan; 36(1):155-62. PubMed ID: 17962375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
